Author

Sophie Barlow

REASONS FOR CHOICE OF ADVANCED THERAPIES (BIOLOGICS AND JAKIS) FOR THE TREATMENT OF ULCERATIVE COLITIS IN EUROPE
REASONS FOR CHOICE OF ADVANCED THERAPIES (BIOLOGICS AND JAKIS) FOR THE TREATMENT OF ULCERATIVE COLITIS IN EUROPE

Sophie Barlow  et al.

IMPACT OF TREATMENT SWITCH ON CLINICAL OUTCOMES IN CROHN’S DISEASE PATIENTS IN THE UNITED STATES AND 5 EUROPEAN COUNTRIES (FRANCE, GERMANY, ITALY, SPAIN, UK)
IMPACT OF TREATMENT SWITCH ON CLINICAL OUTCOMES IN CROHN’S DISEASE PATIENTS IN THE UNITED STATES AND 5 EUROPEAN COUNTRIES (FRANCE, GERMANY, ITALY, SPAIN, UK)

Sophie Barlow  et al.

IMPACT OF SUBOPTIMAL RESPONSE ON CLINICAL AND HUMANISTIC BURDEN IN CROHN’S DISEASE
IMPACT OF SUBOPTIMAL RESPONSE ON CLINICAL AND HUMANISTIC BURDEN IN CROHN’S DISEASE

Sophie Barlow  et al.

OUTCOMES OF EARLY AND LATE ADVANCED THERAPY USE IN PATIENTS WITH ULCERATIVE COLITIS: FINDINGS FROM A EUROPEAN REAL-WORLD STUDY
OUTCOMES OF EARLY AND LATE ADVANCED THERAPY USE IN PATIENTS WITH ULCERATIVE COLITIS: FINDINGS FROM A EUROPEAN REAL-WORLD STUDY

Sophie Barlow  et al.

BURDEN OF BOWEL URGENCY ACROSS SPECIFIC TREATMENT GROUPS AMONG CROHN’S DISEASE PATIENTS – REAL WORLD GLOBAL STUDY ANALYSES
BURDEN OF BOWEL URGENCY ACROSS SPECIFIC TREATMENT GROUPS AMONG CROHN’S DISEASE PATIENTS – REAL WORLD GLOBAL STUDY ANALYSES

Sophie Barlow  et al.

Item 1 - 5 / 5
1